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Abstract
Objective: To analyze the influence of obesity status on immune cell count and concentration of the hormones
cortisol and leptin, in order to establish a relationship among the variables analyzed.
Methods: We recruited 27 obese [body mass index (BMI) ≥ 95th percentile] and 21 non-obese (BMI ≤ 75th
percentile) adolescent boys and girls, aged 15-19 years at the post-pubertal stage. BMI was calculated as body weight
divided by height squared, and body composition was estimated by plethysmography in the Bod PodTM system. Blood
samples were collected to analyze leukocytes, neutrophils, lymphocytes, monocytes, platelets, cortisol, and leptin.
TheKolmogorov-Smirnov testwasperformed, followedby the independentStudent t test in caseof normal distribution.
Significance valueswere set at p<0.05andexpressedasmeans±standarddeviation. The statistical packageSPSS for
Windows version 12.0 was used.
Results: There was no difference between obese and non-obese adolescents in terms of leukocyte, neutrophil,
lymphocyte, monocyte and cortisol serum concentrations. The group of obese adolescents presented higher platelet
and leptin concentrations (p<0.01). Theprevalenceof hyperleptinemiawas25.92% in theobeseadolescents (15.38%
in boys and 35.7% in girls).
Conclusions: Obese adolescents have higher platelet and leptin concentrations in comparison with non-obese
adolescents. It was also found that obese girls presented a higher prevalence of hyperleptinemia than obese boys.
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Introduction
The incidence of obesity and its associated disorders is
increasingmarkedlyworldwide.Obesity predisposes individu-
als to an increased risk of developing many diseases, includ-
ing atherosclerosis, diabetes, nonalcoholic fatty liver disease,
certain cancers, and some immune-mediated disorders, such
as asthma.1
These pathologies seem to be associated with the high
amount of fat found in obese individuals. Adipocytes secrete
several adipokines and acute-phase proteins, which directly
or indirectly increase production and circulation of factors
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related to inflammation.2 Currently obesity is characterized
by chronic inflammation, in parallelwith other complications.2
Adipokinesmay have antagonist actions in the inflamma-
tory process. There are the typically pro-inflammatory ones,
the so-called interleukines IL-1, IL-6, IL-8, theTNFαand those
produced by Th1 cells (IL-2 and interferon-γ),3 leptin and
resistin.4 However, adipokines with anti-inflammatory action
are the antagonists of the IL-1 (IL-1ra) receptor, transforma-
tion growth factor-β (TGF-β), cytokines produced by Th2 cells
(IL-4, IL-5 and IL-10)3 and adiponectin.5 Leptin is the most
abundant one6 and has influence on the immune system and
on platelet activation and segregation.
Data in the literature are controversial with regard to the
reduction in fat mass and alteration in pro-inflammatory
cytokine concentration. Xenachis et al.7 observed that the cir-
culating concentration of TNF-α diminished with the reduc-
tion in body mass, although other studies failed to find this
reduction.8
Another factor that could alter the functionof immunecells
is the hormone cortisol. Cortisol is recognized as a potent hor-
mone responsible for the suppression of various inflamma-
tory and immune reactions.9 Obesity seems to be followed by
various signs of hypothalamic dysfunctions, similar to those
observed in rodents, but usually to a lesser degree.10 Alter-
ations in cortisol concentrations in obesity are related to cen-
tral obesity.11 Rosmond et al.12 found positive correlations
with abdominal circumference and sagittal-abdominal diam-
eter, and more importantly, with some metabolic variables,
such as triglycerides, insulin, HDL cholesterol (inverse pro-
portion), IGF-1 and with blood pressure, i.e., with param-
eters indicative of the metabolic syndrome (MS). To sum up,
central-visceral obesity, theprobablemajormechanismofMS,
is related to an increase in the activity of the
hypothalamus-hypophysis-adrenal axis and a decrease in its
suppressability. In fact, this evidence was observed in previ-
ously investigation developed by our research group.13
In obese individuals the cortisol concentration is
increased,14 which may occur due to the action of leptin in
the hypothalamus-hypophysis-adrenal axis.
Obesity is a chronic metabolic disorder associated with
cardiovascular disease and atherosclerosis. Platelet activa-
tion and aggregation are central processes in the pathophysi-
ology of cardiovascular disease.Meanplatelet volume (MPV),
a determinant of platelet activation, is a newly emerging risk
marker for atherothrombosis.15
A possible factor that induces platelet activation and seg-
regation is leptin, increasing cardiovascular risks. The long
form of the leptin receptor was detected in human platelets
and high concentrations of leptin were reported to promote
platelet aggregation in vitro. These latter observations raise
the possibility that leptin may also promote thrombosis and
contribute to other disorders in obesity.16 As in adults, obese
adolescents present high leptin concentration.17 Viso
González et al.18 demonstrated a state of hyperleptinemia in
obese adolescents.
Therefore, the aim of this study was to analyze the influ-
ence of the obesity status on the immune cell count and con-
centration of the hormones cortisol and leptin.
Methods
Population
In the Ambulatory for Obesity Intervention (CEPE-GEO)
27 obese (BMI ≥ 95th percentile) and 21 non-obese (BMI ≤
75th percentile) adolescents boys and girls of the CDC refer-
ence growth charts19 were recruited, aged 15-19 years and
pubertal stage as assessed by means of the Tanner.20
This is a cross-sectional screening study designed to
evaluate the leukocytes, cortisol and leptin serum levels in
obese and non-obese adolescents. The study was carried out
in accordance with the principles of the Declaration of Hels-
inki and was formally approved by the Research Ethics Com-
mittee of the Universidade Federal de São Paulo (protocol no.
0135/04). Informed consent was obtained from all subjects
and/or their parents. All individualswere subjected to amedi-
cal evaluation by a physician, including a full medical history
and physical examination.
Study protocol
During the first visit, subjects were medically screened,
had their pubertal stage assessed and their anthropometric
profile measured (height, weight, BMI, and body composi-
tion were measured by Bod PodTM).
Anthropometric measurements
Subjectswearing light clothingandnoshoeswereweighed
on a Filizola scale to the nearest 0.1 kg. Height wasmeasured
to the nearest 0.5 cm by using a wall-mounted stadiometer
(Sanny, model ES 2030). BMI was calculated as body weight
divided by height squared. Body composition was estimated
by plethysmography in the Bod PodTM body composition sys-
tem (version 1.69; Life Measurement Instruments, Concord,
CA)21.
Serum analysis
Blood samples were collected in the outpatient clinic
around 08:00 a.m. after an overnight fast. After collection,
the blood was centrifuged for 10 minutes at 5,000 rpm and
stored at -20 oC for future analyses. The materials used for
collection were disposable, adequately labeled and of recog-
nized quality. Blood was collected by a skilled and qualified
technician.
Hemogram
Blood to perform the hemogram was collected in vacuum
tubes with EDTA anticoagulant. Afterwards, a smear was
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taken and the material was stained by the panoptic tech-
nique. The same tube was submitted to an automated sys-
tem (Sysmex SF-3000, Roche Diagnostics, Sydney,
Australia), which uses the flow cytometry methodology,
obtaining the parameters of the red series (hemacias, hemo-
globin, hematocrit and the hematimetric indexes), white
series (total and differential leukocytes) and platelets.
Statistical analysis
The Kolmogorov-Smirnov test was used to verify the
hypothesis of normal distribution, followed by the indepen-
dent Student t test in case of normal distribution. Signifi-
cance values were set at p < 0.05 and expressed as means ±
standard deviation unless otherwise stated. The statistical
package SPSS for Windows version 12.0 was used.
Results
The characteristics of each group are shown in Table 1.
Thebodymass, BMIand fat presented significantly higher val-
ues for obesegroup (p<0.01). In thepresent study theobese
adolescent group had 78.4% more body mass (kg) in com-
parison with the non-obese group (107.95±10.34 and
60.45±8.91 kg, respectively). In the samecontext, the obese
group obtained a 75.5% higher body fat (8.06±4.86 in the
non-obese group and 35.20±8.72% in the obese group) and
the fat-free mass was significantly higher in the obese group
(69.26±9.38 kg) than in the non-obese group (55.28±5.38
kg). On the other hand, the entire group did not differ signifi-
cantly in ageandheight,whencomparisonwasmadebetween
the groups.
In Table 1, note that there was no difference between
obese and non-obese in the leukocyte, neutrophil, lympho-
cyte,monocyte and cortisol serumconcentrations. The group
of obese adolescents presented a higher platelet concentra-
tion (p < 0.01).
Themean and standard deviation concentrations of leptin
were all significantly higher in the obese groups than in the
non-obese groups. Interestingly, the obese girls showed
higher concentration in leptin than boys (21.52±6.58 and
12.58±4.17 ng/mL, respectively) (p < 0.05). In contrast,
Table 1 - Anthropometric variables of obese and non-obese groups: comparison of the biochemical parameters between obese and non-obese
adolescents (values expressed by the mean ± standard deviation from the mean)
Non-obese (n = 21) Obese (n = 27)
Age (Y) 15.37±1.25 15.83±0.87
Body mass (kg) 60.45±8.91 107.95±10.34*
Height (m) 1.72±0.06 1.74±0.07
BMI (kg/m2) 20.41±2.0 35.83±3.88*
Body fat (%) 8.06±4.86 35.20±8.72*
Lean body mass (kg) 55.28±5.38 69.26±9.38*
Neutrophil (1,000/mm3) 3.85±1.06 3.93±1.66
Lymphocytes (1,000/mm3) 2.48±0.55 2.25±0.69
Monocytes (1,000/mm3) 0.43±0.12 0.44±0.29
Cortisol (ug/dL) 9.17±5.09 12.84±5.23
Platelet (1,000/mm3) 212.45±59.72 279.57±43.81*
BMI = body mass index.
* Group obese vs. group non-obese, p ≤ 0.01.
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comparison of leptin in non-obese group was not significant
(Figure 1). The prevalence of hyperleptinemiawas 25.92% in
the obese adolescents (15.38%, boys and 35.7%, girls).
Discussion
To date, this was the first study to the compare immune
cell profile between obese and non-obese adolescents. The
main finding of the present researchwas that obese individu-
als presented a higher platelet count when compared with
non-obese individuals.
Although epidemiological data has shown that obese indi-
viduals have higher white blood counts than lean individuals,
the absolute leukocyte count of obese individuals is generally
within the normal range.22 However, there are almost no
reports that focusedon immunecell counts in obesity and spe-
cifically in obese adolescents.
Another study showed that obese children have high cir-
culating leukocyte counts, in particular neutrophils, mono-
cytes, and lymphocytes.23 Although themechanismsof these
increases are not clear, obesity in children, as in adults, is
related to increased circulating cytokines, like IL-6 and
TNF-α,24 which may contribute to the increased numbers of
circulating leukocytes.25 It is difficult to explain the differ-
ence between the results of the present study and the
above-mentioned studies. Despite the higher leukocytosis
observed in obese child and adult subjects, these leukocytes
levels were within accepted clinical values.
Differently, in our study, no differences were observed for
white immune cell counts betweenobese andnon-obese ado-
lescents. Although an increase in leptin was found in the
present study, which could be related to immune alterations,
this seems to alter the function of cellsmore than it alters their
counts. In this context, leptin seems to participate in
responses related to immune function, such as: inflamma-
tory responses.26
The function and count of immune cells is also influenced
by cortisol. Classically, an increase in the secretion of gluco-
corticoids is found in obese children, adolescent and adult.15
In this study, the comparison of cortisol concentration
betweenobeseandnon-obesegroupswasnot significant. This
can be justified because the non-obese group practiced sys-
tematic physical exercises. The human organism decodes
physical exercise as a stressful stimulus produced by means
of the hypothalamus, a strong sympathetic adrenal dis-
charge, resulting in cortisol release by the cortex of the
supra-renal gland.27
Obesity is a chronic metabolic disorder associated with
cardiovascular disease and atherosclerosis. Platelet activa-
tion and aggregation are central processes in the pathophysi-
ologyof cardiovascular disease.MPV, adeterminant of platelet
activation, is a newly emerging risk marker for atherothrom-
bosis.28 Little is known about the relation between BMI and
MPV levels inobesepatients. Toplak&Wascher29 reported that
after weight loss, the MPV was significantly decreased to ini-
tial values. Cobanet al.28 found thatMPV showedpositive cor-
relationswithBMI level in obesegroup. Thedataof thepresent
study support this hypothesis, showing that obese adoles-
cents present higher platelet counts in comparison with
non-obese adolescents.
Since the literature has concluded that elevation of plate-
let counts and MPV are significantly associated with obesity
and they contribute to the development of several diseases,
significant efforts must be implemented to keep adolescents’
weight within normal limits or to reduce their weight when
they are obese, in order to reduce the potentially harmful
effects of the obesity-induced inflammatory state andathero-
thrombosis risks.
Leptin is a factor that induces platelet activation and
aggregation, thus increasing cardiovascular risks. In addi-
tion, an association of leptin with thrombosis and hemostatic
balance disorders in obesity has been suggested.16
The results of the present study showed that obese ado-
lescents have higher platelet counts in comparison with
non-obese adolescents. In adults, this relationship has
already been presented by Nakata,30 however, in obese ado-
lescents, this hasnotbeendocumented in the literature,which
leaves the subject inconclusive.
The prevalence of hyperleptinemia was higher in obese
girls, 35.7%, vs. 15.38% in obese boys. In the non-obese
groups there was no prevalence of hyperleptinemia. Never-
theless, the platelet count was similar between the genders.
These data suggest that if the hyperleptinemia condition is
not controlled, girls could be more susceptible to cardiovas-
cular risks associated with leptin-dependent platelet activa-
tion and aggregation.
Based on the results found in the present study, it could
be concluded that obese adolescents have higher platelet and
*Obese vs. non-obese, p<0.01
#Girls vs. boys, p<0.05
Figure 1 - Leptin concentrationof adolescent girls andboys: com-
parison between obese and non-obese groups
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leptin concentrations in comparison with non-obese adoles-
cents, a stat that could favor functional alterations and rep-
resent higher risk for disorders associatedwith cardiovascular
diseases. It was also found that obese girls presented higher
prevalence of hyperleptinemia than obese boys. Therefore, it
is reasonable to suggest that treatment for obesity control in
adolescence is relevant to promote and maintain the state of
health and quality of life of this population, and those thera-
pies, such as physical exercise, nutritional, psychological and
medical follow-up could be used as prophylactic tools.
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